Poltreg S.A. (PTG.WA)
- Previous Close
34.40 - Open
35.00 - Bid 34.30 x --
- Ask 34.80 x --
- Day's Range
34.40 - 35.00 - 52 Week Range
33.00 - 56.80 - Volume
537 - Avg. Volume
1,269 - Market Cap (intraday)
162.288M - Beta (5Y Monthly) 0.98
- PE Ratio (TTM)
-- - EPS (TTM)
-3.94 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
54.65
Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases. It engages in the research and development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.
poltreg.techRecent News: PTG.WA
View MorePerformance Overview: PTG.WA
Trailing total returns as of 4/29/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PTG.WA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PTG.WA
View MoreValuation Measures
Market Cap
160.42M
Enterprise Value
116.82M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
305.80
Price/Book (mrq)
2.18
Enterprise Value/Revenue
212.40
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-11.05%
Return on Equity (ttm)
-23.87%
Revenue (ttm)
350k
Net Income Avi to Common (ttm)
-18.71M
Diluted EPS (ttm)
-3.94
Balance Sheet and Cash Flow
Total Cash (mrq)
45.66M
Total Debt/Equity (mrq)
11.51%
Levered Free Cash Flow (ttm)
-21.02M